Accenture is a leading global professional services company that helps clients to build their digital core, transform their operations, and accelerate revenue growth by creating tangible value across their enterprises at speed and scale. Years of investment, in digital, cloud & security strategy, have helped Accenture to evolve as a trusted and viable consulting services provider. Accenture's clients comprise the Fortune Global 100 and the Fortune Global 500. The ability to anticipate large, transformative technology trends and capitalization through mergers and acquisitions, are the keys to the company's success. Accenture reports under five segments: Communications, Media & Technology, Financial Services, Health & Public Service, Products, and Resources. The company's integrated service team meets client needs rapidly and at scale, leveraging Accenture's network of innovation hubs, the company's technology expertise and ecosystem relationships, and our global delivery capabilities....
+See More2025-09-16 09:27:00 Tuesday ET
Stock Synopsis: With a new Python program, we use, adapt, apply, and leverage each of the mainstream Gemini Gen AI models to conduct this comprehensive fund
2017-12-09 08:37:00 Saturday ET
Michael Bloomberg, former NYC mayor and media entrepreneur, criticizes that the Trump administration's tax reform is a trillion dollar blunder because i
2023-02-03 08:27:00 Friday ET
Our proprietary alpha investment model outperforms most stock market indices from 2017 to 2023. Our proprietary alpha investment model outperforms the ma
2019-06-11 12:33:00 Tuesday ET
Dallas Federal Reserve Bank President Robert Kaplan expects the U.S. economy to grow at 2.2%-2.5% in 2019-2020 as inflation rises a bit. In an interview wit
2023-09-07 11:30:00 Thursday ET
Michael Woodford provides the theoretical foundations of monetary policy rules in ever more efficient financial markets. Michael Woodford (2003)
2025-10-31 12:26:00 Friday ET
With respect to wider weight loss treatment and obesity treatment, the global market for GLP-1 medications now grows substantially to benefit more than 1 bi